REVBW
Income statement / Annual
Last year (2024), Revelation Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Revelation Biosciences, Inc.'s net income was -$15.04 B.
See Revelation Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$25,049.00
|
$40,008.00
|
$69,166.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$25,049.00
|
-$40,008.00
|
-$69,166.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$3.55 B
|
$4.15 M
|
$5.38 M
|
$6.91 M
|
$2.56 M
|
$0.00
|
| General & Administrative Expenses |
$4.43 B
|
$4.51 M
|
$5.49 M
|
$5.04 M
|
$1.23 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$144,257.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.43 B
|
$4.51 M
|
$5.49 M
|
$5.04 M
|
$145,492.00
|
$3,638.00
|
| Other Expenses |
$0.00
|
$0.00
|
$34,962.00
|
-$36,352.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$7.98 B
|
$8.66 M
|
$10.86 M
|
$11.95 M
|
$145,492.00
|
$3,638.00
|
| Cost And Expenses |
$0.00
|
$8.66 M
|
$10.86 M
|
$11.95 M
|
$145,492.00
|
$3,638.00
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$10,915.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$25,049.00
|
$40,008.00
|
$69,166.00
|
$3.80 M
|
$171,860.00
|
| EBITDA |
-$7.98 B |
-$95,208.00 |
-$10.84 M |
-$11.93 M |
-$145,492.00 |
-$3,640.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$7.06 B
|
$8.54 M
|
$34,962.00
|
-$36,352.00
|
-$1.49 M
|
$2.00
|
| Income Before Tax |
-$15.04 B
|
-$120,254.00
|
-$10.83 M
|
-$11.99 M
|
-$1.63 M
|
-$3,638.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$34,962.00
|
-$219,776.00
|
-$3,795.82
|
-$171,860.00
|
| Net Income |
-$15.04 B
|
-$120,254.00
|
-$10.79 M
|
-$11.99 M
|
-$1.63 M
|
-$3,638.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-8768.31 |
-0.53 |
-600.77 |
-1275.02 |
-188.18 |
-0.42 |
| EPS Diluted |
-8768.31 |
-0.53 |
-600.77 |
-1275.02 |
-188.18 |
-0.42 |
| Weighted Average Shares Out |
$1.72 M
|
$228,000.00
|
$17,968.00
|
$9,401.31
|
$8,664.47
|
$8,664.47
|
| Weighted Average Shares Out Diluted |
$1.72 M
|
$228,641.00
|
$17,968.00
|
$9,401.31
|
$8,664.47
|
$8,664.47
|
| Link |
|
|
|
|
|
|
